The Legal Process Has Started To Grind Against Heartburn Drug Manufacturers and Others

Product liability and wrongful death lawsuits are being filed accusing companies involved in manufacturing and distributing ranitidine drugs

Wednesday, June 24, 2020 - Hundreds of lawsuits have been filed against a multitude of pharmaceutical and retail companies along the supply chain that includes heartburn and acid reflux medication Zantac, alleging that sufferers that took the over the counter and prescription medicine regularly and for a long time caused them to develop stomach, bladder, esophageal, pancreatic, prostate, breast and a host of other types of cancer. The legal wheels have begun to turn as individual and class action lawsuits are forming. Initial administrative and investigative processes are underway. All that is missing at this point is the one blockbuster jury decision awarding monetary compensation and punitive damages in the hundreds of millions of dollars to ignite media attention and public awareness that individuals may have been the victim of the corporate violations of strict products liability, negligence, breach of warranty, loss of consortium, and wrongful death. If you or a loved one have developed cancer and have taken Zantac or another heartburn or diabetic drug regularly for a long time, you may want to consider speaking with a Zantac Cancer Attorney to see if you can file a claim.

According to PR Newswire, an 18-month discovery process has begun for a class-action lawsuit filed recently alleging that several drug manufacturers and retailers have violated the RICO and the Magnuson-Moss Warranty Act, false advertising and consumer protection statutes and have made billions of dollars of profits knowing that Zantac (ranitidine) medicine used to treat common heartburn and acid reflux conditions caused a variety of cancers when used as directed. PR Newswire.com reported that 238 plaintiffs have formed the class action lawsuit targeting "four brand manufacturers, Boehringer Ingelheim Pharmaceuticals, Inc. ("BI"), GlaxoSmithKline ("GSK"), Pfizer and Sanofi, the Master PI Complaint names 33 generic manufacturers, 4 distributors, 25 retailers, and 3 repackagers as defendants." The lawsuit alleges that the manufactures knew or should have known that the levels of NDMA could increase above the levels the FDA considers safe when exposed to high heat, nitrates in the stomach, and also from being contaminated during the overseas manufacturing process that the FDA has difficulty in monitoring. Sanofi, the maker of Zantac issued a voluntary recall that was followed by the FDA pulling all ranitidine products that tested for high NDMA levels. The deadline for the defendants to answer for the allegations or to file a motion for dismissal is August 23, 2020.

The heartburn product recall comes after blood pressure medication was tested and found to have elevated NDMA levels. Since then, diabetic drug metformin, a type of SGLT2 sodium-glucose transport drug has been found to contain high levels of NDMA. NDMA is a byproduct of manufacturing rocket fuel and is given to laboratory test animals to induce tumors for study. Online testing pharmacy Valisure was the first to come forward with their knowledge of Zantac, the world's best-selling brand of heartburn medication, testing positive for high and potentially harmful levels of NDMA.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.